International Journal of Scientific & Technology Research

IJSTR@Facebook IJSTR@Twitter IJSTR@Linkedin
Home About Us Scope Editorial Board Blog/Latest News Contact Us

IJSTR >> Volume 6 - Issue 5, May 2017 Edition

International Journal of Scientific & Technology Research  
International Journal of Scientific & Technology Research

Website: http://www.ijstr.org

ISSN 2277-8616

Global Outbreaks Of Ebola And It’s Strategic Management

[Full Text]



Humna Sajid Qureshi, Inshal Ashraf, Muhammad Jamshaid, Irfan Bashir, Tehseen Riaz



Ebola Virus, pathogenic, Whole Blood transfusion, haemorrhagic fever, WHO Guidelines



Ebola outbreaks are more prevalent in central and west Africa. Epidemics with their statistical data was analyzed to study and document the signs and symptoms, diagnosis, transmission, incubation period and other disease characterteristics. To predict standard treatment guidelines , control /prevention or the strategic management of ebola disease, Health regulatory authorities on national & international level like WHO and PAHO (Pan American Health Organization) are encouraging the research for the prevention diagnosis and treatment of ebola disease. Some antiviral drugs are found efficacious but they are still in pre-clinical and clinical trials. Although no recommended treatment and vaccination is available to the date but the only approved treatment by WHO is whole blood transfusion of the infected person.



[1] Baron, R. C., McCormick, J. B., & Zubeir, O. A. (1983). Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bulletin of the World Health Organization, 61(6), 997.

[2] Cenciarelli, O., Pietropaoli, S., Malizia, A., Carestia, M., D’Amico, F., Sassolini, A., . . . Tamburrini, A. (2015). Ebola virus disease 2013-2014 outbreak in west Africa: an analysis of the epidemic spread and response. International journal of microbiology, 2015.

[3] Günther, S., Feldmann, H., Geisbert, T. W., Hensley, L. E., Rollin, P. E., Nichol, S. T., . . . Ksiazek, T. G. (2011). Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany. Journal of Infectious Diseases, 204(suppl 3), S785-S790.

[4] Jaax, N. K., Davis, K. J., Geisbert, T. J., Vogel, P., Jaax, G. P., Topper, M., & Jahrling, P. B. (1996). Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Archives of pathology & laboratory medicine, 120(2), 140-155.

[5] Judson, S., Prescott, J., & Munster, V. (2015). Understanding ebola virus transmission. Viruses, 7(2), 511-521.

[6] Lamunu, M., Lutwama, J., Kamugisha, J., Opio, A., Nambooze, J., Ndayimirije, N., & Okware, S. (2004). Containing a haemorrhagic fever epidemic: the Ebola experience in Uganda (October 2000–January 2001). International journal of infectious diseases, 8(1), 27-37.

[7] Muyembe-Tamfum, J.-J., Mulangu, S., Masumu, J., Kayembe, J., Kemp, A., & Paweska, J. T. (2012). Ebola virus outbreaks in Africa: past and present. Onderstepoort Journal of Veterinary Research, 79(2), 06-13.

[8] Panning, M., Laue, T., Ölschlager, S., Eickmann, M., Becker, S., Raith, S., . . . Lundkvist, A. (2007). Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratories. Journal of Infectious Diseases, 196(Supplement 2), S199-S204.

[9] Qiu, X., Wong, G., Audet, J., Bello, A., Fernando, L., Alimonti, J. B., . . . Hiatt, E. (2014). Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature.

[10] Team, W. E. R. (2014). Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections. N Engl J Med, 371(16), 1481-1495.

[11] Weingartl, H. M., Embury-Hyatt, C., Nfon, C., Leung, A., Smith, G., & Kobinger, G. (2012). Transmission of Ebola virus from pigs to non-human primates. Scientific reports, 2.

[12] Zhang, L., & Wang, H. (2014). Forty years of the war against Ebola. Journal of Zhejiang University Science B, 15(9), 761-765.